BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35076441)

  • 21. Pregnancy and the Opioid Crisis: Heightened Effects of COVID-19.
    White A; Lundahl B; Bryan MA; Okifuji A; Smid M; Gordon AJ; Carlston K; Silipigni J; Abdullah W; Krans EE; Kenney A; Cochran G
    J Addict Med; 2022 Jan-Feb 01; 16(1):e2-e4. PubMed ID: 34282083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid treatment programs, telemedicine and COVID-19: A scoping review.
    Chan B; Bougatsos C; Priest KC; McCarty D; Grusing S; Chou R
    Subst Abus; 2022; 43(1):539-546. PubMed ID: 34520702
    [No Abstract]   [Full Text] [Related]  

  • 23. Opioid epidemic spread from Northern and Eastern Europe to Mediterranean Area.
    di Gaudio F; Mortali C; Tini A
    Clin Ter; 2021 May; 172(3):209-210. PubMed ID: 33956038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report.
    Crowley D; Delargy I
    Harm Reduct J; 2020 Jul; 17(1):49. PubMed ID: 32680520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women, opioid use and addiction.
    Goetz TG; Becker JB; Mazure CM
    FASEB J; 2021 Feb; 35(2):e21303. PubMed ID: 33433026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The new services that opioid treatment programs have adopted in response to COVID-19.
    Cantor J; Laurito A
    J Subst Abuse Treat; 2021 Nov; 130():108393. PubMed ID: 34118694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Opioid Epidemic in America: Pandemic Impacts.
    Slater RR; Beverley L
    J Am Acad Orthop Surg; 2022 Oct; 30(20):e1302-e1310. PubMed ID: 35944546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities.
    Jenkins WD; Bolinski R; Bresett J; Van Ham B; Fletcher S; Walters S; Friedman SR; Ezell JM; Pho M; Schneider J; Ouellet L
    J Rural Health; 2021 Jan; 37(1):172-174. PubMed ID: 32277731
    [No Abstract]   [Full Text] [Related]  

  • 29. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
    Cochran G; Bruneau J; Cox N; Gordon AJ
    Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth.
    Cales RH; Cales SC; Shreffler J; Huecker MR
    J Subst Abuse Treat; 2022 Feb; 133():108543. PubMed ID: 34210567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020.
    Niles JK; Gudin J; Radcliff J; Kaufman HW
    Popul Health Manag; 2021 Feb; 24(S1):S43-S51. PubMed ID: 33031013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.
    Brothers S; Viera A; Heimer R
    J Subst Abuse Treat; 2021 Dec; 131():108449. PubMed ID: 34098303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons.
    Bandara S; Kennedy-Hendricks A; Merritt S; Barry CL; Saloner B
    J Addict Med; 2020; 14(5):e257-e260. PubMed ID: 32868681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN).
    Ducharme LJ; Wiley TRA; Mulford CF; Su ZI; Zur JB
    J Subst Abuse Treat; 2021 Sep; 128():108307. PubMed ID: 33531212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing opioid overdose deaths: The vision for the HEALing communities study.
    Chandler RK; Villani J; Clarke T; McCance-Katz EF; Volkow ND
    Drug Alcohol Depend; 2020 Dec; 217():108329. PubMed ID: 33075691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid use and misuse in Europe: COVID-19 new challenges?
    Torrens M; Fonseca F
    Eur Neuropsychopharmacol; 2022 Jan; 54():67-69. PubMed ID: 34565653
    [No Abstract]   [Full Text] [Related]  

  • 37. Pregnant Patients Using Opioids: Treatment Access Barriers in the Age of COVID-19.
    Lensch AC; Hairston E; Carter G; Jones HE
    J Addict Med; 2022 Jan-Feb 01; 16(1):e44-e47. PubMed ID: 33606424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A recent history of opioid use in the US: Three decades of change.
    Dayer LE; Painter JT; McCain K; King J; Cullen J; Foster HR
    Subst Use Misuse; 2019; 54(2):331-339. PubMed ID: 30572776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update: COVID-19 Upends Progress on Opioid Crisis.
    Am J Nurs; 2020 Oct; 120(10):16. PubMed ID: 32976135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2).
    Leppla IE; Gross MS
    J Addict Med; 2020; 14(4):e1-e3. PubMed ID: 32412931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.